Donald Trump's top pick to lead Medicare, celebrity doctor Mehmet Oz, has a glaring conflict of interest: that he was ...
More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
On Nov. 26, the Biden administration announced a plan to require Medicare and Medicaid to cover weight loss medications like ...
The Federal Trade Commission requires influencers to disclose when a post is a paid advertisement — and a public interest ...
West Virginia’s Public Employee Insurance Agency (PEIA) is in a bind. Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save money while ...
Though some doctors have been trying to classify “obesity” as a “chronic illness,” being fat and being ill aren’t the same ...
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...
Since 2018, Ozempic's net price has fallen from $531 to $290, or 45%. Since 2020, Rybelsus' net price has dropped from $376 to $296, or 21%. In contrast, Wegovy's net price has increased 21% since ...